ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,139.60
0.68%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.775
-0.61%
Bitcoin
67,431.23
-1.06%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Takeda Pharmaceutical Co Ltd (0RN3)

  7. Takeda Pharmaceutical Co Ltd (0RN3) News

0RN3

Takeda Pharmaceutical (0RN3)

Takeda Pharmaceutical Co Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0RN3
DateTimeSourceHeadlineSymbolCompany
06/24/20245:00AMAlliance NewsAlliance NewsIN BRIEF: Hutchmed China notes Takeda obtains EU approval for FruzaqlaLSE:0RN3Takeda Pharmaceutical Co Ltd
05/09/20244:36AMAlliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit sinks as expenses mountLSE:0RN3Takeda Pharmaceutical Co Ltd
04/22/20243:41PMAlliance NewsAlliance NewsTakeda, Astellas and Sumitomo to create new drug discovery companyLSE:0RN3Takeda Pharmaceutical Co Ltd
03/27/20248:56AMPR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
03/27/20248:53AMPR Newswire (US)Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAELSE:0RN3Takeda Pharmaceutical Co Ltd
11/09/20237:16AMAlliance NewsAlliance NewsHutchmed hails Takeda's fruquintinib approval from US for cancer formLSE:0RN3Takeda Pharmaceutical Co Ltd
10/30/20238:24AMAlliance NewsAlliance NewsTakeda Pharmaceutical first half profit falls as costs outpace revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
09/29/20235:12AMAlliance NewsAlliance NewsHutchmed notes Takeda submits fruquintinib drug application in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
09/22/202310:15AMPR Newswire (US)Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and OlderLSE:0RN3Takeda Pharmaceutical Co Ltd
07/27/20235:26AMAlliance NewsAlliance NewsTakeda keeps guidance unchanged despite drop in quarterly profitLSE:0RN3Takeda Pharmaceutical Co Ltd
07/12/20238:22AMAlliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
07/12/202312:16AMAlliance NewsAlliance NewsJapan's Takeda pulls dengue vaccine candidate in USLSE:0RN3Takeda Pharmaceutical Co Ltd
06/16/20233:51AMAlliance NewsAlliance NewsHutchmed, Takeda Fresco-2 study published in The LancetLSE:0RN3Takeda Pharmaceutical Co Ltd
05/11/20236:51AMAlliance NewsAlliance NewsTOP NEWS: Takeda outlook downbeat as Covid wanes, hit from genericsLSE:0RN3Takeda Pharmaceutical Co Ltd
02/02/20235:57AMAlliance NewsAlliance NewsTakeda Pharmaceutical set for annual guidance as 9-month results upLSE:0RN3Takeda Pharmaceutical Co Ltd
12/08/202211:49AMAlliance NewsAlliance NewsTakeda Pharmaceutical gets EC approval for dengue vaccineLSE:0RN3Takeda Pharmaceutical Co Ltd
11/23/20227:49AMAlliance NewsAlliance NewsIN BRIEF: USD FDA accepts Takeda's TAK-003 for priority reviewLSE:0RN3Takeda Pharmaceutical Co Ltd
07/28/202212:10PMAlliance NewsAlliance NewsTakeda first quarter profit drops despite revenue increaseLSE:0RN3Takeda Pharmaceutical Co Ltd
05/11/20228:23AMAlliance NewsAlliance NewsTakeda annual profit drops on investment losses but revenue climbsLSE:0RN3Takeda Pharmaceutical Co Ltd
04/19/20223:19AMAlliance NewsAlliance NewsTakeda's Nuvaxovid vaccine approved for use in JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
09/07/20211:10AMAlliance NewsAlliance NewsTakeda inks deal with Japan's government to supply Novavax vaccinesLSE:0RN3Takeda Pharmaceutical Co Ltd
06/09/202112:22PMPR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
06/09/202112:21PMPR Newswire (US)Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient communityLSE:0RN3Takeda Pharmaceutical Co Ltd
05/11/20213:30AMAlliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical profit surges; guides boosted revenueLSE:0RN3Takeda Pharmaceutical Co Ltd
10/29/20203:41AMAlliance NewsAlliance NewsTOP NEWS: Takeda Pharmaceutical Ups Guidance As Profit Rises In HalfLSE:0RN3Takeda Pharmaceutical Co Ltd
08/07/20206:25AMAlliance NewsAlliance NewsNovavax Turns To Takeda To Manufacture Covid-19 Vaccine In JapanLSE:0RN3Takeda Pharmaceutical Co Ltd
08/03/20206:35AMAlliance NewsAlliance NewsGLOBAL TRADING UPDATE SUMMARY: Murata's First-Quarter Profit Drops 15%LSE:0RN3Takeda Pharmaceutical Co Ltd
07/31/20206:04AMAlliance NewsAlliance NewsTOP NEWS: Takeda Profit More Than Triples In Quarter; Ups GuidanceLSE:0RN3Takeda Pharmaceutical Co Ltd
06/29/20205:06AMAlliance NewsAlliance NewsTakeda Earnings To Be Hurt By Novartis Pulling Xiidra ApplicationLSE:0RN3Takeda Pharmaceutical Co Ltd
06/22/20205:10AMAlliance NewsAlliance NewsTakeda Pharmaceutical To Get USD564 Million One-Off Profit BoostLSE:0RN3Takeda Pharmaceutical Co Ltd
 Showing the most relevant articles for your search:LSE:0RN3

Your Recent History

NASDAQ
NNOX
Nano X Imaging
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved